SPDR Health Care E.T.F.

XLV-N

NYSEARCA:XLV

106.41
0.34 (0.32%)

Analysis and Opinions about XLV-N

Signal
Opinion
Expert
PAST TOP PICK
PAST TOP PICK
August 5, 2020
(A Top Pick May 07/20, Up 8%) Healthcare sector is a bit exhausted right now, and seeing relative weakness. He's walked back from it a bit. Coming up to an election, healthcare can become a political football.
Show full opinionHide full opinion
(A Top Pick May 07/20, Up 8%) Healthcare sector is a bit exhausted right now, and seeing relative weakness. He's walked back from it a bit. Coming up to an election, healthcare can become a political football.
TOP PICK
TOP PICK
May 7, 2020
The healthcare sector has outperformed the S&P since February. There is a lot of money going into this sector. It tends to do well this time of year also. We also have to be more cautious in election years but it will be harder for this sector to be kicked back and forth like a football.
Show full opinionHide full opinion
The healthcare sector has outperformed the S&P since February. There is a lot of money going into this sector. It tends to do well this time of year also. We also have to be more cautious in election years but it will be harder for this sector to be kicked back and forth like a football.
PAST TOP PICK
PAST TOP PICK
September 24, 2019
(A Top Pick May 09/19, Up 4%) Seasonality ends Oct. 24. It's been faltering lately. The US election campaign is a headwind and will continue to overhang. He may exit this.
Show full opinionHide full opinion
(A Top Pick May 09/19, Up 4%) Seasonality ends Oct. 24. It's been faltering lately. The US election campaign is a headwind and will continue to overhang. He may exit this.
PAST TOP PICK
PAST TOP PICK
September 11, 2019
(A Top Pick Sep 12/18, Down 1%) He was stopped out of this. The medical devices space is good. Biotech services, are under huge pressure. This ETF was a little too inclusive so he exited.
Show full opinionHide full opinion
(A Top Pick Sep 12/18, Down 1%) He was stopped out of this. The medical devices space is good. Biotech services, are under huge pressure. This ETF was a little too inclusive so he exited.
COMMENT
COMMENT
September 6, 2019

US Healthcare For knee replacements and implants he likes SNN-N. He does not prefer the ETFs, such as XLV-N, because they hold too broad of an array of companies, including the big drug companies that are under pressure. He would focus on the tool and device space instead.

Show full opinionHide full opinion

US Healthcare For knee replacements and implants he likes SNN-N. He does not prefer the ETFs, such as XLV-N, because they hold too broad of an array of companies, including the big drug companies that are under pressure. He would focus on the tool and device space instead.

PAST TOP PICK
PAST TOP PICK
August 7, 2019
(A Top Pick Aug 07/18, Up 1%) He was stopped out a while ago. Managed care got hit and became politicized. The sector went neutral, so he went into medical devices instead.
Show full opinionHide full opinion
(A Top Pick Aug 07/18, Up 1%) He was stopped out a while ago. Managed care got hit and became politicized. The sector went neutral, so he went into medical devices instead.
TOP PICK
TOP PICK
May 9, 2019
It is defensive with a seasonal period from May first to the beginning of August. Investors get attracted to this sector at this time of the year because it is defensive. It has started to outperform the market. It is less exposed to the China/US trade deal. It is not a bad place to be. It is a place to hide out in.
Show full opinionHide full opinion
It is defensive with a seasonal period from May first to the beginning of August. Investors get attracted to this sector at this time of the year because it is defensive. It has started to outperform the market. It is less exposed to the China/US trade deal. It is not a bad place to be. It is a place to hide out in.
TOP PICK
TOP PICK
January 8, 2019
Buying beta. Can drop with the market but high quality market exposure. Tends to have high cash flow, large cap, robust companies, well diversified. Yield 1.6%.
Show full opinionHide full opinion
Buying beta. Can drop with the market but high quality market exposure. Tends to have high cash flow, large cap, robust companies, well diversified. Yield 1.6%.
TOP PICK
TOP PICK
December 6, 2018
You want to focus your portfolio on leadership. He likes healthcare late cycle. These tend to have a higher cap. This is the largest diversified exposure in his portfolio.
Show full opinionHide full opinion
You want to focus your portfolio on leadership. He likes healthcare late cycle. These tend to have a higher cap. This is the largest diversified exposure in his portfolio.
TOP PICK
TOP PICK
October 15, 2018

It's the largest by far in this space and cheap at 0.13% MER. Carries the biggies in healthcare with J&J, Pfizer as the top two holdings. It's highly liquid. He wants US dollars now, which is another plus. Also likes ZUB-T, but he prefers U.S. dollars.

Show full opinionHide full opinion

It's the largest by far in this space and cheap at 0.13% MER. Carries the biggies in healthcare with J&J, Pfizer as the top two holdings. It's highly liquid. He wants US dollars now, which is another plus. Also likes ZUB-T, but he prefers U.S. dollars.

TOP PICK
TOP PICK
September 12, 2018

He feels the market is near the late stages of the bull run, but feels this balanced portfolio will continue to work well.

Show full opinionHide full opinion

He feels the market is near the late stages of the bull run, but feels this balanced portfolio will continue to work well.

TOP PICK
TOP PICK
August 7, 2018

This tends to be late stage and has been growing rapidly in the last 3-to-4 months. It is just starting to break out. Within the underlying sector, more industries are starting to do well pharma, services, distributors and hospitals are all improving and the US-based policy risk seems to be toning down. (Analysts’ price target was not provided)

Show full opinionHide full opinion

This tends to be late stage and has been growing rapidly in the last 3-to-4 months. It is just starting to break out. Within the underlying sector, more industries are starting to do well pharma, services, distributors and hospitals are all improving and the US-based policy risk seems to be toning down. (Analysts’ price target was not provided)

BUY
BUY
January 19, 2018

A US healthcare ETF? He would buy one of the Spider sector ETF's. This one has very, very low costs, and is very liquid. It is well diversified. If you want something that has Canadian hedging, then you can buy ZUH-T from the Bank of Montréal.

Show full opinionHide full opinion

A US healthcare ETF? He would buy one of the Spider sector ETF's. This one has very, very low costs, and is very liquid. It is well diversified. If you want something that has Canadian hedging, then you can buy ZUH-T from the Bank of Montréal.

BUY
BUY
January 17, 2018

The 2nd best performing sector in the S&P 500. He likes it, but doesn't have any exposure to healthcare right now. It's a great ETF. With an $.805 Cdn dollar, he would definitely be buying the name.

Show full opinionHide full opinion

The 2nd best performing sector in the S&P 500. He likes it, but doesn't have any exposure to healthcare right now. It's a great ETF. With an $.805 Cdn dollar, he would definitely be buying the name.

PAST TOP PICK
PAST TOP PICK
January 3, 2018

(A Top Pick Feb 17/17. Up 16%.) He still likes this. There are very few sectors that are in secular bull markets. This is one of them. This should be a core holding for every Canadian investor.

Show full opinionHide full opinion

(A Top Pick Feb 17/17. Up 16%.) He still likes this. There are very few sectors that are in secular bull markets. This is one of them. This should be a core holding for every Canadian investor.

PAST TOP PICK
PAST TOP PICK
June 30, 2017

(A Top Pick April 18/16. Up 14.37%.) He still likes this. Healthcare is in a secular bull market. The trend started in 2012. It is still a Hold.

Show full opinionHide full opinion

(A Top Pick April 18/16. Up 14.37%.) He still likes this. Healthcare is in a secular bull market. The trend started in 2012. It is still a Hold.

PAST TOP PICK
PAST TOP PICK
May 11, 2017

(A Top Pick April 18/16. Up 8%.) If this can get above the peak it hit in March, it is going to really accelerate. He would like this one longer-term. (See Top Picks.)

Show full opinionHide full opinion

(A Top Pick April 18/16. Up 8%.) If this can get above the peak it hit in March, it is going to really accelerate. He would like this one longer-term. (See Top Picks.)

TOP PICK
TOP PICK
February 17, 2017

Just the big names in US healthcare. We have seen the bottom in here. It is one of the strongest sectors out there right now. We saw some rotation last week. It is in a secular bull market and we are at the beginning of it. It has a really good valuation. The political football that it has been is going to die down.

Show full opinionHide full opinion

Just the big names in US healthcare. We have seen the bottom in here. It is one of the strongest sectors out there right now. We saw some rotation last week. It is in a secular bull market and we are at the beginning of it. It has a really good valuation. The political football that it has been is going to die down.

COMMENT
COMMENT
October 7, 2016

Good time for a US healthcare ETF? This should be a good area to get into because of an aging population. Demographics are certainly in favour. If he was going to do anything, this would be the one he would go with.

Show full opinionHide full opinion

Good time for a US healthcare ETF? This should be a good area to get into because of an aging population. Demographics are certainly in favour. If he was going to do anything, this would be the one he would go with.

COMMENT
COMMENT
June 30, 2016

Which stocks for RESP and University in 8 years? He would use healthcares such as SPDR Health Care (XLV-N) or SPDR Pharma (XPH-N). These are in a secular bull market. You could also use Van Eck Vectors Biotech (BBH-Q). This gives you a little bit of mix of all 3 sectors. He would suggest 40% and 40% on the first 2 and maybe 20% in the Biotechs.

Show full opinionHide full opinion

Which stocks for RESP and University in 8 years? He would use healthcares such as SPDR Health Care (XLV-N) or SPDR Pharma (XPH-N). These are in a secular bull market. You could also use Van Eck Vectors Biotech (BBH-Q). This gives you a little bit of mix of all 3 sectors. He would suggest 40% and 40% on the first 2 and maybe 20% in the Biotechs.

DON'T BUY
DON'T BUY
May 5, 2016

Healthcare does better in August and into October. But it ran up since February. We have that political football. Be careful because it is an election year.

Show full opinionHide full opinion

Healthcare does better in August and into October. But it ran up since February. We have that political football. Be careful because it is an election year.

TOP PICK
TOP PICK
April 18, 2016

There are very few sectors that are in a bull market on a secular basis. This is one of them. It started in 2014. Was a little bit of a football recently. He started by taking a small position of 2.5%. This is coming into a strong seasonal period.

Show full opinionHide full opinion

There are very few sectors that are in a bull market on a secular basis. This is one of them. It started in 2014. Was a little bit of a football recently. He started by taking a small position of 2.5%. This is coming into a strong seasonal period.

PAST TOP PICK
PAST TOP PICK
December 10, 2015

(A Top Pick June 29/15. Down 3.4%.) Likes healthcare and wouldn’t sell this. Healthcare is one of those areas that is a good position to have in a portfolio.

Show full opinionHide full opinion

(A Top Pick June 29/15. Down 3.4%.) Likes healthcare and wouldn’t sell this. Healthcare is one of those areas that is a good position to have in a portfolio.

PAST TOP PICK
PAST TOP PICK
October 15, 2015

(Top Pick Oct 31/14, Up 2.23%) It was way higher two months ago. He got out a month ago. He still likes it long term. He thinks there will be good opportunities to grab this for the long term in the next couple of months.

Show full opinionHide full opinion

(Top Pick Oct 31/14, Up 2.23%) It was way higher two months ago. He got out a month ago. He still likes it long term. He thinks there will be good opportunities to grab this for the long term in the next couple of months.

PAST TOP PICK
PAST TOP PICK
October 15, 2015

(A Top Pick June 29/15. Down 6.39%.) Healthcare and biotech have been hit pretty hard lately. He really likes this on a longer-term basis. This is an area that continues to be very, very important, and this will continue to do well. If you own, continue to Hold. Still a Buy.

Show full opinionHide full opinion

(A Top Pick June 29/15. Down 6.39%.) Healthcare and biotech have been hit pretty hard lately. He really likes this on a longer-term basis. This is an area that continues to be very, very important, and this will continue to do well. If you own, continue to Hold. Still a Buy.

TOP PICK
TOP PICK
June 29, 2015

The healthcare sector should probably be one of your core sectors holdings and you can hold this for the long-term. It is a play on major US healthcare providers. There is going to be continued consolidation in the sector, because margins will be squeezed.

Show full opinionHide full opinion

The healthcare sector should probably be one of your core sectors holdings and you can hold this for the long-term. It is a play on major US healthcare providers. There is going to be continued consolidation in the sector, because margins will be squeezed.

TOP PICK
TOP PICK
June 24, 2015

All 3 picks are in healthcare. There is a huge wave of baby boomers that will be coming through this market and making demands on the healthcare system. This will exhaust itself in probably 15 years. This one has a lot of the big guys in that, such as Pfizer, Johnson & Johnson, Merck, etc.

Show full opinionHide full opinion

All 3 picks are in healthcare. There is a huge wave of baby boomers that will be coming through this market and making demands on the healthcare system. This will exhaust itself in probably 15 years. This one has a lot of the big guys in that, such as Pfizer, Johnson & Johnson, Merck, etc.

TOP PICK
TOP PICK
October 31, 2014

Healthcare. Chart shows a V bottom this month. As a longer-term investor, he would like to hold this for a while. If it came back to the breakout level in the low $60, he would like to buy some more. Healthcare is a generational thing that we are just embarking on.

Show full opinionHide full opinion

Healthcare. Chart shows a V bottom this month. As a longer-term investor, he would like to hold this for a while. If it came back to the breakout level in the low $60, he would like to buy some more. Healthcare is a generational thing that we are just embarking on.

DON'T BUY
DON'T BUY
June 18, 2013

Healthcare. This is strictly US with about 48% pharma. Likes the sector but thinks the ETF has too much pharma.

Show full opinionHide full opinion

Healthcare. This is strictly US with about 48% pharma. Likes the sector but thinks the ETF has too much pharma.

COMMENT
COMMENT
January 16, 2013

Which ETF would you recommend to play the healthcare sector in the US? SPDR Health Care (XLV-N) generally does a pretty good job. If you don’t want to through the US, there is also BMO EqWt US HthCare Hedged CAD (ZUH-T) on the Canadian market.

Show full opinionHide full opinion

Which ETF would you recommend to play the healthcare sector in the US? SPDR Health Care (XLV-N) generally does a pretty good job. If you don’t want to through the US, there is also BMO EqWt US HthCare Hedged CAD (ZUH-T) on the Canadian market.

PAST TOP PICK
PAST TOP PICK
May 9, 2008
(A Top Pick Oct 27/07. Down 11%.) This was basically a defensive play to the end of the year and was up at that time. Still a Buy.
Show full opinionHide full opinion
(A Top Pick Oct 27/07. Down 11%.) This was basically a defensive play to the end of the year and was up at that time. Still a Buy.
TOP PICK
TOP PICK
October 26, 2007
(SPDR Health Care E.T.F) Health care does well in the summer time, people like to take from aggressive positions and put money in defensive positions during holidays. Should sell at end of the year, before J.P Morgan health care conference takes place.
Show full opinionHide full opinion
(SPDR Health Care E.T.F) Health care does well in the summer time, people like to take from aggressive positions and put money in defensive positions during holidays. Should sell at end of the year, before J.P Morgan health care conference takes place.
TOP PICK
TOP PICK
May 14, 2004
Congress approved a Medicare bill that will put $500 billion into the health care sector.
Show full opinionHide full opinion
Congress approved a Medicare bill that will put $500 billion into the health care sector.
Showing 1 to 33 of 33 entries
  • «
  • 1
  • »

SPDR Health Care E.T.F.(XLV-N) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 4

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 4

Stockchase rating for SPDR Health Care E.T.F. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

SPDR Health Care E.T.F.(XLV-N) Frequently Asked Questions

What is SPDR Health Care E.T.F. stock symbol?

SPDR Health Care E.T.F. is a American stock, trading under the symbol XLV-N on the NYSE Arca (XLV). It is usually referred to as AMEX:XLV or XLV-N

Is SPDR Health Care E.T.F. a buy or a sell?

In the last year, 4 stock analysts published opinions about XLV-N. 4 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is PAST TOP PICK. Read the latest stock experts' ratings for SPDR Health Care E.T.F..

Is SPDR Health Care E.T.F. a good investment or a top pick?

SPDR Health Care E.T.F. was recommended as a Top Pick by Brooke Thackray on 2020-08-05. Read the latest stock experts ratings for SPDR Health Care E.T.F..

Why is SPDR Health Care E.T.F. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is SPDR Health Care E.T.F. worth watching?

4 stock analysts on Stockchase covered SPDR Health Care E.T.F. In the last year. It is a trending stock that is worth watching.

What is SPDR Health Care E.T.F. stock price?

On 2020-08-07, SPDR Health Care E.T.F. (XLV-N) stock closed at a price of $106.41.